首页> 外文OA文献 >4CPS-111 Clinical and economic impact of infliximab biosimilar Inflectra in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis naïve and switched patients: 5 years of follow-up

【2h】

4CPS-111 Clinical and economic impact of infliximab biosimilar Inflectra in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis naïve and switched patients: 5 years of follow-up

机译：4CPS-111英夫利昔单抗生物纤维腹泻中的临床和经济影响类风湿性关节炎，银屑病关节病和强直性脊柱炎Naïve和切换患者：5年后续行动

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
J Borras; A Gracia-Pérez; A Valcuende Rosique; MDe Castera; JD Rosique; FJ Abad;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CLINICAL AND ECONOMIC IMPACT OF THE USE OF INFLIXIMAB BIOSIMILAR INFLECTRA IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHROPATHY AND ANKYLOSING SPONDYLITIS PATIENTS [J] . Borras Blasco J., Gracia-Perez A., Castera D., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：在风湿性关节炎，银屑病性关节炎和强直性脊柱炎患者中使用英美昔布类真菌感染的临床和经济影响
2. Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients [J] . Borrás-BlascoJ., Gracia-PérezA., Rosique-RoblesJ.D., Expert opinion on biological therapy . 2014,第2期

机译：在风湿性关节炎，银屑病关节炎和强直性脊柱炎患者中，每周一次使用依那西普25 mg的临床和经济影响
3. A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis [J] . Clinical drug investigation . 2020,第6期

机译：5年来回顾性分析类风湿性关节炎和强直性脊柱炎患者英夫利昔单抗生物仿生CT-P13的药物存活，安全性和有效性
4. No adverse physiological responses to infrared whole body hyperthermia in patients with rheumatoid arthritis and ankylosing spondylitis compared to healthy subjects. [C] . F.G.J. OOSTERVELD, E. KOOPMAN, J. OLDE SCHOLTENHUIS, Advances in biomedical research . 2010

机译：与健康受试者相比，类风湿性关节炎和强直性脊柱炎患者对红外全身热疗没有不利的生理反应。
5. Clinical research on the preventive efficacy of sulfasalazine against Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis [D] . 布川貴博 2019

机译：柳氮磺胺吡啶对类风湿关节炎肺炎克氏杆菌的预防作用的临床研究
6. Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis ankylosing spondyloarthritis and psoriatic arthritis across Germany [O] . John Waller, Emma Sullivan, James Piercy, 2017

机译：在整个德国评估英夫利昔单抗生物仿制药在类风湿性关节炎强直性脊柱关节炎和银屑病关节炎中的医师和患者接受度
7. Clinical and Economic Impact of The Use Of Infliximab Biosimilar Inflectra In Rheumatoid Arthritis, Psoriatic Arthropathy And Ankylosing Spondylitis Patients [O] . J Borras Blasco, A Gracia-Pérez, D Casterá, 2016

机译：incuximab生物纤维腹泻的临床和经济影响类风湿性关节炎，银屑病关节病和强直性脊柱炎患者

4CPS-111 Clinical and economic impact of infliximab biosimilar Inflectra in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis naïve and switched patients: 5 years of follow-up

著录项

相似文献

相关主题

期刊订阅